Covered recipient · General Payments record
IYAD SYOUFI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$11,530.42
- Reported across 725 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,617.63 | 156 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $317.79 | 9 |
| Lilly USA, LLC | $262.26 | 18 |
| Novo Nordisk AS | $240.03 | 24 |
| Amgen Inc. | $204.73 | 11 |
| Abbott Laboratories | $189.01 | 18 |
| Medtronic, Inc. | $166.28 | 11 |
| Radius Health, Inc. | $136.44 | 8 |
| Averitas Pharma Inc. | $130.71 | 6 |
| BETA BIONICS, INC. | $124.81 | 7 |
| DEXCOM, INC. | $88.73 | 4 |
| MannKind Corporation | $74.54 | 5 |
| Insulet Corporation | $68.25 | 4 |
| SANOFI-AVENTIS U.S. LLC | $66.46 | 3 |
| Xeris Pharmaceuticals, Inc. | $55.83 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.77 | 3 |
| CeQur Corporation | $47.35 | 1 |
| Amneal Pharmaceuticals LLC | $44.65 | 3 |
| Alexion Pharmaceuticals, Inc. | $43.08 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $42.94 | 2 |
| Verity Pharmaceuticals Inc. | $37.17 | 2 |
| ABBVIE INC. | $37.08 | 2 |
| Amphastar Pharmaceuticals, Inc. | $35.82 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $32.32 | 2 |
| CHIESI USA, INC. | $27.60 | 1 |
| VIVUS LLC | $23.56 | 1 |
| Ascendis Pharma Inc | $19.57 | 1 |
| Alvogen Inc | $18.59 | 1 |
| Ascensia Diabetes Care US Inc. | $16.67 | 1 |
| TOLMAR, INC. | $16.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (156)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.